Back to search

National and Kapodistrian University of Athens

Network signature techniques for drug discovery in pulmonary fibrosis

Abstract

dc:description

Fibrotic diseases cover a spectrum of systemic and organ specific diseases that affect a large portion of the population, currently without cure. Idiopathic Pulmonary Fibrosis (IPF) is an interstitial disease as well as one of the most common and studied fibrotic diseases which still remains an active research target. Understanding the underlying biological mechanisms and respective interactions of a disease remains an elusive, time consuming and costly task. Computational methodologies that propose communities and reveal respective relationships can be of great value as they can help expedite the process of identifying how perturbations in a single can affect other pathways. Drug or Drug Repositioning (DR) is a methodology where already existing drugs are tested against diseases outside their initial spectrum to reduce the high cost and long periods of new drug development. The 4 main objectives of this PhD thesis is to (i) identify key differentially expressed genes of fibrotic diseases, (ii) explore the respective perturbed biological pathways and (iii) suggest repurposed drugs as potential anti-fibrotic candidates for further testing and (iv) identify which fibrotic diseases resemble based on common terms, to potentially pursue common regimens. We analyze transcriptomics datasets containing fibrotic and normal samples to identify key genes that are implicated in fibrotic diseases. We use these genes as input in DR tools and then propose a novel drug re-ranking methodology via a scoring formula that consolidates standard scores with structural, functional and side effect scores. Following, we present a analysis and community detection methodology, based on Random Walk theory, where a walker crosses a pathway-to-pathway network under the guidance of a disease-related map. The latter is a gene network that we construct by integrating multi-source information regarding a specific disease. The most frequent trajectories highlight communities of pathways that are expected to be strongly related to the disease under study. By applying our pathway analysis methodology on 9 different fibrotic maladies, we identify various common highlighted pathways as well as unique entries for some of the diseases.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Karatzas, Evangelos
  • Καρατζάς, Ευάγγελος

Subjects

dc:subject × 14

Rights

dc:rights
Statement dc:rights
  • BY
Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/47361

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Karatzas, Evangelos; Καρατζάς, Ευάγγελος. Network signature techniques for drug discovery in pulmonary fibrosis. National and Kapodistrian University of Athens, 2020. http://hdl.handle.net/10442/hedi/47361